Результаты поиска - Zhiping, Tang
- Отображение 1 - 3 результаты of 3
-
1
-
2
-
3
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients по Liping Zhong, Lu Gan, Bing Wang, Liang Cao, Fei Yao, Wenlin Gong, Hongmei Peng, Zhiming Deng, Guoyou Xiao, Xiyu Liu, Jintong Na, Desong Xia, Xianjun Yu, Zhikun Zhang, Xiang Bangde, Yu Huo, Dan Yan, Zhixin Dong, Fang Fang, Yun Ma, Guanqiao Jin, Danke Su, Xiuli Liu, Rui Li, H Liao, Chao Tang, Jian He, Zhiping Tang, Shilai Zhang, Bingqing Qiu, Zhi Yang, Lihui Yang, Ziqin Chen, Mengsi Zeng, Ronghua Feng, Jie-ge Jiao, Yuan Liao, Tinghua Wang, Liangliang Wu, Zhengcheng Mi, Ziqun Liu, Si Shi, Kun Zhang, Wei Shi, Yongxiang Zhao
Опубликовано 2025Artigo
Инструменты поиска:
Связанные темы
Biology
Cancer
Cancer research
Genetics
ATG5
Apoptosis
Astrobiology
Aurora kinase
Autophagy
Biochemistry
Bioinformatics
Cancer cell
Cell biology
Cell cycle
Clinical trial
Kinase
Mechanistic target of rapamycin
Oncolytic virus
PI3K/AKT/mTOR pathway
Refractory (planetary science)
Sequestosome 1
Virology
Virus